Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives The aim of this randomised GCP-controlled trial is to clarify whether combination therapy with the antibiotic azithromycin and hydroxychloroquine via anti-inflammation/immune modulation, antiviral efficacy and pre-emptive treatment of supra-infections can shorten hospitalisation...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Pradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, Therese Sophie Lapperre, Josefin Viktoria Eklöf, Kjell Erik Julius Håkansson, Andrea Browatzki, Casper Tidemansen, Jon Torgny Wilcke, Julie Janner, Vibeke Gottlieb, Howraman Meteran, Celeste Porsbjerg, Birgitte Lindegaard Madsen, Mia Moberg, Lars Pedersen, Thomas Lars Benfield, Jens Dilling Lundgren, Filip Krag Knop, Tor Biering-Sørensen, Muzhda Ghanizada, Tine Peick Sonne, Uffe Christian Steinholtz Bødtger, Sidse Graff Jensen, Daniel Bech Rasmussen, Eva Brøndum, Oliver Djurhuus Tupper, Susanne Wiemann Sørensen, Gitte Alstrup, Christian Borbjerg Laursen, Ulla Weinrich Møller, Asger Sverrild, Jens-Ulrik Stæhr Jensen
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2020-06-01
Sarja:Trials
Aiheet:
COVID-19
Randomised controlled trial
protocol
azithromycin
hydroxychloroquine
respiratory infections
Linkit:http://link.springer.com/article/10.1186/s13063-020-04409-9

Internet

http://link.springer.com/article/10.1186/s13063-020-04409-9

Samankaltaisia teoksia